NCI Reports Q2 EPS $0.22 Vs Est $0.19, Sales $85.8M Vs Est $83.56M; Sees Q3 EPS $0.18-$0.20 Vs Est $0.19 & Revs $80M-$86M Vs Est $84.87M; Sees FY EPS 0.76-$0.82 Vs Est $0.76 & Revs $327M-$343M Vs Est $334.89M